GNH USA

Europe — EMA

Nitrofurantoïne Activase (Nitrofurantoin)

GNH USA supplies Nitrofurantoïne Activase (Nitrofurantoin), a nitrofuran antibacterial for uncomplicated urinary tract infections.

Request sourcing

1
Pack/s

What is Nitrofurantoin?

Nitrofurantoin, the active ingredient in Nitrofurantoïne Activase, is a nitrofuran antibacterial presented as an oral tablet for oral use. It treats uncomplicated urinary tract infections in adult patients. GNH USA supplies Nitrofurantoïne Activase as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Nitrofurantoin used for?

Nitrofurantoin is used to treat bacterial infections of the urinary tract. - Uncomplicated urinary tract infection: eradicates susceptible uropathogens in the bladder, relieving symptoms. - Acute cystitis: provides bactericidal activity that clears infection and reduces discomfort. - Prophylaxis of recurrent urinary tract infection: reduces recurrence when administered as directed by a prescriber.

What are the side effects of Nitrofurantoin?

Nitrofurantoin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: occasional upset stomach after dosing. - Diarrhea: loose stools that may occur during therapy. - Headache: mild to moderate headache reported by some patients. - Metallic taste: transient alteration in taste perception.

Serious or Rare Side Effects: - Pulmonary toxicity: interstitial lung disease or acute respiratory distress, requiring immediate medical attention. - Hepatic injury: signs of liver dysfunction such as jaundice or elevated enzymes. - Hemolytic anemia in G6PD‑deficient patients: rapid drop in red blood cells. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

What precautions apply to Nitrofurantoin?

Before prescribing Nitrofurantoin, clinicians should consider several safety factors. - Renal function: assess creatinine clearance, as reduced renal function limits urinary excretion. - G6PD deficiency: avoid in patients with known deficiency due to risk of hemolysis. - Pregnancy: category B, generally considered safe but use only if clearly needed. - Elderly patients: monitor for reduced renal function and potential toxicity. - Concomitant use with drugs that may cause lung injury: observe for respiratory symptoms. - Store at room temperature: keep in the original container, protect from moisture and light.

What does Nitrofurantoin interact with?

Nitrofurantoin can interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: may decrease nitrofurantoin absorption. - Probenecid: can increase nitrofurantoin plasma concentrations, raising toxicity risk. - Cimetidine: may raise nitrofurantoin levels, enhancing adverse effects. - Warfarin: potentiates anticoagulant effect, requiring closer INR monitoring.

Moderate Interactions (Monitor Closely): - Fluoroquinolones: additive risk of tendonitis or tendon rupture. - Macrolide antibiotics (e.g., erythromycin): may increase risk of liver toxicity when used together.

Frequently asked questions

What is Nitrofurantoïne Activase used for?+
Nitrofurantoïne Activase contains nitrofurantoin, an oral antibacterial indicated for the treatment of uncomplicated urinary tract infections caused by susceptible bacteria. It is prescribed to clear infection in the bladder and relieve associated symptoms such as dysuria and frequency.
How does nitrofurantoin work?+
Nitrofurantoin is reduced by bacterial enzymes to reactive metabolites that damage bacterial DNA, ribosomal proteins, and carbohydrate‑metabolizing enzymes. This multi‑target attack leads to bactericidal activity that is concentrated in the urine because the drug is rapidly excreted unchanged.
What is the usual dose of Nitrofurantoïne Activase?+
The specific dose and duration are determined by the prescribing clinician based on the patient’s condition, renal function, and local guidelines. Nitrofurantoin dosing is individualized and should follow the prescriber’s instructions.
Is Nitrofurantoïne Activase safe during pregnancy or breastfeeding?+
Nitrofurantoin is classified as pregnancy category B, indicating no evidence of risk in animal studies and limited human data. It may be used during pregnancy when clearly needed, but it is generally avoided near term. Breastfeeding mothers should consult their physician, as small amounts can be excreted in milk.
How do I order Nitrofurantoïne Activase from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials. The sales team will then provide pricing, availability, shipping details and any necessary import documentation.
How does Nitrofurantoïne Activase compare with other UTI antibiotics?+
Nitrofurantoin offers targeted urinary tract activity with minimal systemic exposure, making it effective for uncomplicated infections caused by common uropathogens. Compared with broad‑spectrum agents such as trimethoprim‑sulfamethoxazole, it has a lower risk of promoting resistance but may be less suitable for patients with reduced renal function.
How should Nitrofurantoïne Activase be stored and handled?+
Store the tablets at room temperature, below 25 °C, in the original packaging to protect from moisture and light. Keep out of reach of children and do not use if the packaging is damaged or the tablets appear discolored.
How is Nitrofurantoïne Activase administered?+
Nitrofurantoïne Activase is taken orally, usually with food or milk to reduce gastrointestinal irritation. The tablets should be swallowed whole with a full glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.
What are the most serious risks associated with Nitrofurantoïne Activase?+
Serious adverse reactions include pulmonary toxicity (interstitial lung disease or acute respiratory distress), hepatic injury, hemolytic anemia in patients with G6PD deficiency, and severe skin reactions such as Stevens‑Johnson syndrome. Any signs of respiratory difficulty, jaundice, dark urine, or rash require immediate medical evaluation.
Who should not use Nitrofurantoïne Activase?+
Nitrofurantoin is contraindicated in patients with severe renal impairment (creatinine clearance < 30 mL/min), known hypersensitivity to nitrofurantoin, or G6PD deficiency due to the risk of hemolysis. It should also be avoided in late pregnancy (≥ 38 weeks) and in individuals with a history of pulmonary or hepatic reactions to the drug.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Nitrofurantoin
Route
Oral Use
Manufacturer
Activase Pharmaceuticals Limited
Origin
EU

Related products